A comparison of the central actions of prostaglandins A1, E1, E2, F1alpha, and F2alpha in the rat. II. The effect of intraventricular prostaglandins on the action of some drugs and on the level and turnover of biogenic amines in the rat brain.
Prostaglandins (PGs) injected into the right lateral brain ventricle (i.v.c.) of the rat increased the sleeping time induced by hexobarbital, chloral hydrate, and ethanol. PGE1 and PGE2 intensified chlorpromazine-induced catalepsy, inhibited amphetamine hyperactivity, and significantly depressed the amphetamine-induced stereotypy. NA concentrations were decreased by PGE1 and PGE2 and were increased by PGF2alpha. PGF2alpha increased both 5-HT and 5-HIAA levels in rat brain. "Total" ACh concentrations were increased by PGF1alpha and PGF2alpha. PGE1, PGE2, and PGF2alpha enhanced the turnover of NA, DA, and 5-HT. PGE2 counteracted the decreased activity induced by alpha-MT and abolished the hypothermic action of alpha-MT. PGF2alpha had little effect on the activity of PCPA pretreated rats, whereas the higher doses of PGF2alpha increased body temperature in these animals.
D000109:Acetylcholine / Q000378:metabolism; D000661:Amphetamine / Q000037:antagonists & inhibitors; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001831:Body Temperature / Q000187:drug effects; D001921:Brain / Q000378:metabolism*; D002375:Catalepsy / Q000139:chemically induced; D002746:Chlorpromazine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000494:pharmacology; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D007276:Injections, Intraventricular; D008297:Male; D008781:Methyltyrosines / Q000037:antagonists & inhibitors; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D011453:Prostaglandins / Q000494:pharmacology*; D011454:Prostaglandins A / Q000494:pharmacology; D011458:Prostaglandins E / Q000494:pharmacology; D011460:Prostaglandins F / Q000494:pharmacology; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D013239:Stereotyped Behavior / Q000187:drug effects
D001679:Biogenic Amines; D006993:Hypnotics and Sedatives; D008781:Methyltyrosines; D011453:Prostaglandins; D011454:Prostaglandins A; D011458:Prostaglandins E; D011460:Prostaglandins F; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D000661:Amphetamine; D000109:Acetylcholine; D010134:Fenclonine; D002746:Chlorpromazine; D004298:Dopamine; D009638:Norepinephrine